Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriane Fugh-Berman

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
American Family Physician|September 6, 2011
Compromising the medical literature: the hidden influence of industry-biased articlesAdriane Fugh-Berman, Jay Siwek
Journal of the American Board of Family Medicine : JABFM|March 18, 2020
Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED)Jinhyun Jung, Adriane Fugh-Berman
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 4, 2013
Physicians under the influence: social psychology and industry marketing strategiesSunita Sah, Adriane Fugh-Berman
Journal of General Internal Medicine|March 11, 2021
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not EnoughJoel Lexchin, Adriane Fugh-Berman
The Virtual Mentor : VM|December 14, 2012
"This may sting a bit": cutting CME's ties to pharmaAdriane Fugh-Berman, Sharon Batt
Journal of General Internal Medicine|March 25, 2009
Do new drugs increase life expectancy? A critique of a Manhattan Institute paperDean Baker, Adriane Fugh-Berman
Journal of Medical Ethics|December 18, 2015
CME stands for commercial medical education: and ACCME still won't address the issueAdriane Fugh-Berman, Alycia Hogenmiller
American Family Physician|July 30, 2025
Menopausal Hormone Therapy: Limited Benefits, Significant HarmsAdriane Fugh-Berman, Barbara Mintzes
International Journal of Social Determinants of Health and Health Services|April 9, 2024
Parkinson's Disease Psychosis and the Marketing of PimavanserinDaisy Daeschler, Adriane Fugh-Berman
JAMA Internal Medicine|July 31, 2023
Are New Alzheimer Drugs Better Than Older Drugs?Susan Molchan, Adriane Fugh-Berman
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
American Family Physician|September 6, 2011
Compromising the medical literature: the hidden influence of industry-biased articlesAdriane Fugh-Berman, Jay Siwek
Journal of the American Board of Family Medicine : JABFM|March 18, 2020
Marketing Messages in Continuing Medical Education (CME) Modules on Binge-Eating Disorder (BED)Jinhyun Jung, Adriane Fugh-Berman
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|October 4, 2013
Physicians under the influence: social psychology and industry marketing strategiesSunita Sah, Adriane Fugh-Berman
Journal of General Internal Medicine|March 11, 2021
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not EnoughJoel Lexchin, Adriane Fugh-Berman
The Virtual Mentor : VM|December 14, 2012
"This may sting a bit": cutting CME's ties to pharmaAdriane Fugh-Berman, Sharon Batt
Journal of General Internal Medicine|March 25, 2009
Do new drugs increase life expectancy? A critique of a Manhattan Institute paperDean Baker, Adriane Fugh-Berman
Journal of Medical Ethics|December 18, 2015
CME stands for commercial medical education: and ACCME still won't address the issueAdriane Fugh-Berman, Alycia Hogenmiller
American Family Physician|July 30, 2025
Menopausal Hormone Therapy: Limited Benefits, Significant HarmsAdriane Fugh-Berman, Barbara Mintzes
International Journal of Social Determinants of Health and Health Services|April 9, 2024
Parkinson's Disease Psychosis and the Marketing of PimavanserinDaisy Daeschler, Adriane Fugh-Berman
JAMA Internal Medicine|July 31, 2023
Are New Alzheimer Drugs Better Than Older Drugs?Susan Molchan, Adriane Fugh-Berman
Pageof 7